AstraZeneca PLC Board Change

Friday, 27 February 2009

AstraZeneca today announced that Håkan Mogren, Non-Executive Deputy Chairman of AstraZeneca PLC, will retire from the Board at the close of the company’s AGM on 30 April 2009.

Louis Schweitzer, Chairman of AstraZeneca PLC, said: “As Chief Executive Officer of Astra AB, and subsequently Deputy Chairman of AstraZeneca, Håkan has made an excellent contribution to our business. He was instrumental in the formation of AstraZeneca and has brought a wealth of experience and sound judgement to our Board decisions. His fellow Directors and I thank him for his distinguished contribution to the company over two decades and wish him a long and very happy retirement.”

About AstraZeneca
AstraZeneca is a major international healthcare business engaged in the research, development, manufacturing and marketing of meaningful prescription medicines and supplier for healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies with healthcare sales of US$ 31.6 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infectious disease medicines. For more information about AstraZeneca, please visit:

Media Enquiries:
Chris Sampson +44 20 7304 5130 (24 hours)
Neil McCrae +44 207 304 5045 (24 hours)
Sarah Lindgreen +44 20 7304 5033 (24 hours)

Investor Enquiries UK:
Jonathan Hunt +44 207 304 5087 mob: +44 7775 704032
Karl Hard +44 207 304 5322 mob: +44 7789 654364

Investor Enquiries US:
Ed Seage +1 302 886 4065 mob: +1 302 373 1361
Jorgen Winroth +1 212 579 0506 mob: +1 917 612 4043


  • Corporate and financial